Two weeks after Teva touted promising long-term data for its Sanofi-partnered bowel disease drug, the Israeli pharma ...
Blackstone Inc. (NYSE:BX) is one of the 10 Best Asset Management Stocks to Buy Right Now. Top 100 Places Where the Rich ...
Research and development continues to play a central role in the strategy of Teva Pharmaceutical Industries Ltd. Efforts are ...
Teva is undergoing a major business transition, but dividend investors should check out this 6.3% yielding competitor instead ...
Duquesne Family Office's billionaire boss meaningfully pared down two high-flying stocks in the fourth quarter and made a ...
Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting TL1ADuvakitug is ...
The deal adds to a growing biotech presence for Blackstone and supports testing of a drug competing with rival therapies from Merck and Roche.
Corcept Therapeutics lost its patent-infringement battle with Teva Pharmaceutical Industries, exposing Corcept to more competition from generic drugs. The ruling from the U.S. Court of Appeals for the ...
Teva®, a division of Deckers Brands (NYSE: DECK), introduces its Spring 2026 collection, the next evolution of its For ...
Pfizer , Teva and other major drugmakers have failed to persuade a federal judge to disqualify a former prosecutor who is representing private health insurers suing the companies after he spearheaded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results